Literature DB >> 3332110

Interleukin 2 and its receptor: structure, function and therapeutic potential.

M Malkovský1, P M Sondel.   

Abstract

In this review, salient molecular, biochemical and functional features of human interleukin 2 (IL-2), its membrane receptor, and its clinical relevance are outlined. We also describe experimental systems, where observed biological or pharmacological effects of IL-2 could be applied to corresponding clinical situations. In particular, IL-2 has been intensively studied in the context of cancer therapy. We discuss the rationale for the use of IL-2 in cancer treatment and our experience in this area. A better understanding of the IL-2 system and, specifically, the nature of signals transduced through it will allow us to manipulate the immune response in a variety of different ways, resulting in new approaches to investigation of immune responsiveness in general. This may have a profound impact on clinical medicine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3332110     DOI: 10.1016/0268-960x(87)90027-0

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  5 in total

1.  Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.

Authors:  Marc Buyse; Pierre Squifflet; Beverly J Lange; Todd A Alonzo; Richard A Larson; Jonathan E Kolitz; Stephen L George; Clara D Bloomfield; Sylvie Castaigne; Sylvie Chevret; Didier Blaise; Dominique Maraninchi; Kathryn J Lucchesi; Tomasz Burzykowski
Journal:  Blood       Date:  2011-04-25       Impact factor: 22.113

Review 2.  The interleukins in acquired disease.

Authors:  M Malkovský; P M Sondel; W Strober; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

Review 3.  The clinical immunobiology of interleukin-2: potential modified uses for improved cancer treatment.

Authors:  S D Voss; G Weil-Hillman; J A Hank; J A Sosman; P M Sondel
Journal:  Bull N Y Acad Med       Date:  1989-01

Review 4.  The cytokine response to physical activity and training.

Authors:  A I Moldoveanu; R J Shephard; P N Shek
Journal:  Sports Med       Date:  2001-02       Impact factor: 11.136

5.  Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2.

Authors:  P Lissoni; F Brivio; S Pittalis; M S Perego; A Ardizzoia; O Mauri; S Barni; S Crispino; G Tancini
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.